NFKB1 and ovarian cancer: While prior work has demonstrated potential mechanisms by which non-canonical NF-κB signaling may contribute to ovarian cancer pathogenesis, this data provides a crucial clinical link that expression of a non-canonical NF-κB transcription factor is associated with ovarian cancer prognosis, and interventions to inhibit non-canonical NF-κB signaling should be explored as novel therapies to limit ovarian cancer progression and optimize survival outcomes.